You are general counsel to a large healthcare products company that has agreed to acquire a medical devices company in a public merger for $25 billion in cash and stock. The business rationale for the acquisition is your company?s desire to enter the market for heart rhythm devices?implanted defibrillators and pacemakers?a market segment in which the target is one of three leading producers.